Treatment of Inflammatory Facial Acne Vulgaris with a Solid-state Dual Wavelength 1,319 and 589 nm Laser and 2.5% Benzoyl peroxide Versus 2.5% Benzoyl peroxide alone: A Split Face, Randomized Controlled Trial

Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital0 个研究点目标入组 20 人开始时间: 2022年10月3日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1.Healthy males and females between 18 to 50 years old
•2.Patients who have moderate bilateral facial inflammatory acne with the presence of at least five acne papules or pustules per each side of the face
•3.Fitzpatrick skin Types III to V
•4.Patients willing to follow up and comply with the study
•protocol who appreciates to participate in this study by signing the consent form

•1.Pregnant or lactating woman
•2.Patients who had received oral vitamin A derivatives in the past 3 months
•3.Patients who had received any other systemic or topical acne therapies, alpha hydroxy acid or glycolic acid, beta hydroxy acid or salicylic acid within 1 month
•4.Patients who had received oral contraceptives for within 3 months
•5.Patients receiving facial laser treatments within the past 3 months
•6.Patients with history of photosensitive disease
•7.Patients with any medical condition that might affect acne and wound healing process
•8.Patients who withdrew from the study

发起方

Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital